glp-1 receptor agonists and cancer risk in adults with obesity GLP-1 receptor agonist use and
Description
GLP-1 is a natural hormone made in the gut thats released after we eat
But it soon became apparent that just targeting this hormone would not work (Molteni, Chen)
H.SeinoS.et al
Habener drew on the skills of several young researchers
In terms of efficacy, after 24 weeks of treatment, the changes in body weight for different doses in the Retatrutide group were: -2.1% for the placebo group, -7.2% for the 1 mg group, -12.9% for the 4 mg group, -17.3% for the 8 mg group, and -17.5% for the 12 mg group
doi: 10.1016/S2213-8587(21)00203-5 [DOI] [PubMed] [Google Scholar] 31
